EMIT 2000 Mycophenolic Acid Assay*

MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The EMIT® 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.


  • Results available within 10 minutes
  • Utilizes plasma samples - no pretreatment required
  • Assay can be performed alongside 3 other immunosuppressive drugs
  • Correlates to the HPLC reference method



  • Streamlined ISD monitoring for enhanced productivity
  • Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system

Assay Specifications

  EMIT 2000 MPA Assay
Product Code 6R919UL
Sample Type EDTA or Heparinized plasma
Pretreatment None
Reportable Range 0.1 μg/mL–15 μg/mL
Calibration With new reagent lot
Reagent Stability Opened - until expiration date


Learn more about the V-Twin® and Viva-E® Drug Testing Systems

Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting. 

*Not available for sale in the U.S.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

Did this information help you?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you